Retraction

Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells

Citations (23)

23
Total Citations
1
Post-Retraction
(4.3%)
22
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
60 Days since retraction (latest)
Enhanced induction of apoptosis in chronic myeloid leukemia cells through synergistic effect of telomerase inhibitor MST-312 and imatinib
Najibe Karami, Amir Abbas Navidinia, Mohsen Ehsan et al. (5 authors)
Molecular Biology Reports
Published: Nov 2024
60 days after retraction
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia
Tales Henrique Andrade da Mota, Ricardo Camargo, Estefânia Rodrigues Biojone et al. (6 authors)
Genes Open Access
Published: Mar 2023
8 citations
558 days before retraction
Telomerase‐based therapies in haematological malignancies
Ali Rafat, Khadijeh Dizaji Asl, Zeinab Mazloumi et al. (7 authors)
Cell Biochemistry and Function
Published: Feb 2022
14 citations
960 days before retraction
Interaction of the mTERT telomerase catalytic subunit with the c-Abl tyrosine kinase in mouse granulosa cells
Aylin Yaba, Sami Ağuş, Ecem Yıldırım et al. (5 authors)
Journal of Receptors and Signal Transduction
Published: Mar 2020
4 citations
1659 days before retraction
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
Limengmeng Wang, Haowen Xiao, Xing Zhang et al. (5 authors)
Journal of Hematology & Oncology Open Access
Published: Aug 2014
49 citations
3683 days before retraction
REACTIVE OXYGEN SPECIES AND TELOMERE DYSFUNCTION: INVESTIGATING THE UNDERLYING MECHANISMS OF AGING AND RELATED DISEASES
Carrie-Ann Gordon
Unknown Journal
Published: Aug 2014
3701 days before retraction
Synthesis of oligonucleotides with glucosamine at the 3′-position and evaluation of their biological activity
Xiong‐Jian Luo, Takahiro Sugiura, Remi Nakashima et al. (5 authors)
Bioorganic & Medicinal Chemistry Letters Open Access
Published: May 2013
10 citations
4139 days before retraction
First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation
Pier Paolo Piccaluga, Paolini, Bertuzzi et al. (5 authors)
Journal of Blood Medicine Open Access
Published: Nov 2012
16 citations
4339 days before retraction
Nilotinib versus imatinib
Rumiana Bakalova, Zhivko Zhelev, L. Spasov
Cancer Open Access
Published: Apr 2012
4 citations
4529 days before retraction
hTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications
Laure Deville, Josette Hillion, Frédéric Pendino et al. (6 authors)
Molecular Cancer Therapeutics Open Access
Published: Mar 2011
24 citations
4949 days before retraction
The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Markéta Gančarčíková, Zuzana Zemanová, Jana Březinová et al. (7 authors)
PubMed
Published: Jan 2010
20 citations
5374 days before retraction
Telomerase regulation in hematological cancers: A matter of stemness?
Laure Deville, Josette Hillion, E. Segal
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Open Access
Published: Feb 2009
27 citations
5701 days before retraction
Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.
Zhanxiang Wang, Louis M. Pelus
PubMed
Published: Jan 2008
4 citations
6105 days before retraction
Chemically modified symmetric and asymmetric duplex RNAs: An enhanced stability to nuclease degradation and gene silencing effect
Takanori Kubo, Zhivko Zhelev, Hideki Ohba et al. (4 authors)
Biochemical and Biophysical Research Communications
Published: Oct 2007
30 citations
6168 days before retraction
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia
Louise J. Campbell, Carrie Fidler, Helen Eagleton et al. (9 authors)
Leukemia
Published: Feb 2006
56 citations
6782 days before retraction
Telomere and telomerase in hematological malignancies
Ajlan Tükün, Güvem Gümüş‐Akay
Unknown Journal
Published: Jan 2006
2 citations
6835 days before retraction
Expression of T-STAR gene is associated with regulation of telomerase activity in human colon cancer cell line HCT-116
Ling Zhang
World Journal of Gastroenterology Open Access
Published: Jan 2006
11 citations
6835 days before retraction
Nonradioactive telomerase activity assay by microchip electrophoresis: Privileges to the classical gel electrophoresis assay
Zhivko Zhelev, Rumiana Bakalova, Ashraf A. Ewis et al. (6 authors)
Electrophoresis
Published: Aug 2005
5 citations
6988 days before retraction
The importance of the telomere and telomerase system in hematological malignancies
Ron Ram, Orit Uziel, Meir Lahav
Leukemia & lymphoma/Leukemia and lymphoma
Published: Aug 2005
11 citations
6988 days before retraction
Quantum Dot-Based Western Blot Technology for Ultrasensitive Detection of Tracer Proteins
Rumiana Bakalova, Zhivko Zhelev, Hideki Ohba et al. (4 authors)
Journal of the American Chemical Society
Published: Jun 2005
136 citations
7046 days before retraction
Dysregulated expression of the major telomerase components in leukaemic stem cells
M W Drummond, S F Hoare, Aileen Monaghan et al. (7 authors)
Leukemia
Published: Jan 2005
41 citations
7181 days before retraction
Inhibition of <i>bcr‐abl</i> and/or <i>c‐abl</i> gene expression by small interfering, double‐stranded RNAs
Hideki Ohba, Zhivko Zhelev, Rumiana Bakalova et al. (8 authors)
Cancer Open Access
Published: Jul 2004
22 citations
7363 days before retraction
Suppression of bcr‐abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study)
Zhivko Zhelev, Rumiana Bakalova, Hideki Ohba et al. (7 authors)
FEBS Letters
Published: Jul 2004
25 citations
7384 days before retraction
Quick Stats
Total Citations: 23
Years Since Retraction: 1.2 year
Open Access: Yes
Last Checked: Jul 24, 2025